As we get deeper into flu season, a new type of the influenza virus has been identified, the Centers for Disease Control and ...

In a Phase 3 trial of more than 18,000 volunteers across three countries, an mRNA influenza vaccine from Pfizer has ...

Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported.

ANSWER: Both colds and influenza (the “flu”) are respiratory illnesses that are caused by viruses. Influenza is caused specifically by the influenza viruses, which come in two main types (A and B).

Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot demonstrating 34.5% greater efficacy compared to a control vaccine. | Pfizer has ...

HealthDay News — A quadrivalent nucleoside-modified messenger RNA (modRNA) influenza vaccine is superior to a licensed inactivated quadrivalent influenza vaccine, according to a study published in the ...

Cell-based influenza vaccines were superior to egg-based vaccines across patient populations during a recent influenza season ...

In a recent review published in the journal Nature Reviews Immunology, researchers discussed the limitations of current influenza vaccines and the potential for future vaccines to induce both T-cell ...

Several companies, including GSK, Sanofi and CSL Seqirus are beginning to ship influenza vaccine for the upcoming season 2024/25 flu season. GSK has started shipping doses of its trivalent influenza ...

Pfizer-funded study finds a next-gen mRNA flu shot works better against current strains — but causes more short-term side ...

A new influenza strain spreading internationally could bring an early flu season to California, according to health experts. They said the strain, with the full name H3N2 subclade K, is a mismatch for ...

The vaccine has been approved by HSA for use in individuals aged 2 to 49 years. Read more at straitstimes.com. Read more at ...